SB 201-PHARMA BD & EMPLOYEES; DRUG DIST/MANUFAC  1:58:09 PM CHAIR COSTELLO announced the consideration of SB 201; "An Act relating to the Board of Pharmacy; relating to the licensing and inspection of certain facilities located outside the state; relating to drug supply chain security; and creating a position of executive administrator for the Board of Pharmacy." She noted this is the second hearing. CHAIR COSTELLO continued public testimony. DIRK WHITE, past president of the Board of Pharmacy, offered to answer questions on SB 201. 1:59:47 PM SENATOR GIESSEL moved to report SB 201, labeled 29-LS1482\A, from committee with individual recommendations and attached fiscal note. CHAIR COSTELLO announced that without objection, SB 201 is reported from the Senate Labor and Commerce Standing Committee.